Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas

Epigenetics

Volumn 7, Issue 4, 2012, Pages 400-408

  Mahoney, Sarah E ^a   Yao, Zizhen ^a   Keyes, C Chip ^a   Tapscott, Stephen J ^a,b   Diede, Scott J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

DNA methylation; Epigenetics; Polycomb; Rhabdomyosarcoma

Indexed keywords

ARISTALESS LIKE HOMEOBOX 3; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 8A; HOMEODOMAIN PROTEIN; IROQUOIS HOMEOBOX 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN DNAJ; PROTEIN DNAJA4; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HES 5; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA DENATURATION; DNA METHYLATION; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRESCHOOL CHILD; PROMOTER REGION; RHABDOMYOSARCOMA; SCHOOL CHILD; SKELETAL MUSCLE; TISSUE DIFFERENTIATION;

EID: 84860572092     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.19463     Document Type: Article

References (39)

1. Paulino AC, Okcu MF. Rhabdomyosarcoma. Curr Probl Cancer 2008; 32:7-34; PMID:18206520; http://dx.doi.org/10.1016/j.currproblcancer.2007.11.001.
2. Kikuchi K, Rubin BP, Keller C. Developmental origins of fusion-negative rhabdomyosarcomas. Curr Top Dev Biol 2011; 96:33-56; PMID:21621066.
3. Sorensen PHB, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 2002; 20:2672-9; PMID:12039929; http://dx.doi.org/10.1200/JCO.2002.03.137.
4. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985; 316:330-4; PMID:2991766; http://dx.doi.org/10.1038/316330a0.
5. Onyango P, Feinberg AP. A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. Proc Natl Acad Sci USA 2011; 108:16759-64; PMID:21940503; http://dx.doi.org/10.1073/pnas.1110904108.
6. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010; 19:698-711; PMID:21074720; http://dx.doi.org/10.1016/j.devcel.2010.10.005.
7. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89-92; PMID:6185846; http://dx.doi.org/10.1038/301089a0.
8. Goldstein M, Meller I, Orr-Urtreger A. FGFR1 overexpression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG and BMP4 genes. Genes Chromosomes Cancer 2007; 46:1028-38; PMID:17696196; http://dx.doi.org/10.1002/gcc.20489.
9. Gastaldi T, Bonvini P, Sartori F, Marrone A, Iolascon A, Rosolen A. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. Carcinogenesis 2006; 27:1758-67; PMID:16537559; http://dx.doi.org/10.1093/carcin/bgl008.
10. Chen B, Dias P, Jenkins JJ, 3rd, Savell VH, Parham DM. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 1998; 152:1071-9; PMID:9546368.
11. Kurmasheva RT, Peterson CA, Parham DM, Chen B, McDonald RE, Cooney CA. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas. Pediatr Blood Cancer 2005; 44:328-37; PMID:15602708; http://dx.doi.org/10.1002/pbc.20285.
12. Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002; 21:4345-9; PMID:12082624; http://dx.doi.org/10.1038/sj.onc.1205446.
13. Lollini PL, De Giovanni C, Del Re B, Landuzzi L, Nicoletti G, Prodi G, et al. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res 1989; 49:3631-6; PMID:2471586.
14. Diede SJ, Guenthoer J, Geng LN, Mahoney SE, Marotta M, Olson JM, et al. DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proc Natl Acad Sci USA 2010; 107:234-9; PMID:19966297; http://dx.doi.org/10.1073/pnas.0907606106.
15. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123-36; PMID:16618801; http://dx.doi.org/10.1101/gad.381706.
16. Kalushkova A, Fryknäs M, Lemaire M, Fristedt C, Agarwal P, Eriksson M, et al. Polycomb target genes are silenced in multiple myeloma. PLoS One 2010; 5:11483; PMID:20634887; http://dx.doi.org/10.1371/journal.pone.0011483.
17. Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, et al. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene 2010; 29:5923-34; PMID:20697356; http://dx.doi.org/10.1038/onc.2010.322.
18. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, et al. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008; 68:4494-9; PMID:18559491; http://dx.doi.org/10.1158/0008-5472.CAN-07-6509.
19. Guo X, Liu W, Pan Y, Ni P, Ji J, Guo L, et al. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene 2010; 29:3908-20; PMID:20440264; http://dx.doi.org/10.1038/onc.2010.143.
20. Wimmer K, Zhu XX, Rouillard JM, Ambros PF, Lamb BJ, Kuick R, et al. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosomes Cancer 2002; 33:285-94; PMID:11807986; http://dx.doi.org/10.1002/gcc.10030.
21. Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, et al. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer 2011; 18:465-78; PMID:21636702; http://dx.doi.org/10.1530/ERC-11-0083.
22. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, et al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 2003; 23:8429-39; PMID:14612389; http://dx.doi.org/10.1128/MCB.23.23.8429-39.2003.
23. Wakana K, Akiyama Y, Aso T, Yuasa Y. Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett 2006; 241:281-8; PMID:16337738; http://dx.doi.org/10.1016/j.canlet.2005.10.039.
24. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, et al. Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 2004; 10:7917-24; PMID:15585625; http://dx.doi.org/10.1158/1078-0432.CCR-04-1140.
25. Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, et al. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 2011; 6:388-94; PMID:21081840; http://dx.doi.org/10.4161/epi.6.3.14056.
26. Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, et al. A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med 2011; 208:689-702; PMID:21464220; http://dx.doi.org/10.1084/jem.20102099.
27. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, Fernandez AF, et al. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 2009; 4:255-64; PMID:19550145.
28. Hitoshi S, Ishino Y, Kumar A, Jasmine S, Tanaka KF, Kondo T, et al. Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells. Nat Neurosci 2011; 14:957-64;PMID:21765423; http://dx.doi.org/10.1038/nn.2875.
29. Zage PE, Nolo R, Fang W, Stewart J, Garcia-Manero G, Zweidler-McKay PA. Notch pathway activation induces neuroblastoma tumor cell growth arrest. Pediatr Blood Cancer 2011; 58:682-9; PMID:21744479; http://dx.doi.org/10.1002/pbc.23202.
30. Majmundar AJ, Wong WJ, Simon MC. Hypoxiainducible factors and the response to hypoxic stress. Mol Cell 2010; 40:294-309; PMID:20965423; http://dx.doi.org/10.1016/j.molcel.2010.09.022.
31. Koivunen P, Tiainen P, Hyvärinen J, Williams KE, Sormunen R, Klaus SJ, et al. An endoplasmic reticulum transmembrane prolyl-4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J Biol Chem 2007; 282:30544-52; PMID:17726031;http://dx.doi.org/10.1074/jbc.M704988200
32. Ramírez-Peinado S, Alcázar-Limones F, Lagares-Tena L, El Mjiyad N, Caro-Maldonado A, Tirado OM, et al. 2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res 2011; 71:6796-806; PMID:21911456; http://dx.doi.org/10.1158/0008-5472.CAN-11-0759.
33. Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Mol Cancer Ther 2007; 6:732-41; PMID:17308069; http://dx.doi.org/10.1158/1535-7163.MCT-06-0407.
34. Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, et al. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci USA 2011; 108:149-58; PMID:21551099; http://dx.doi.org/10.1073/pnas.1102223108.
35. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, et al. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 2009; 8:172-5; PMID:19106613; http://dx.doi.org/10.4161/cc.8.1.7292.
36. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18:2627-38; PMID:15520282;http://dx.doi.org/10.1101/gad.1241904.
37. Yang Z, MacQuarrie KL, Analau E, Tyler AE, Dilworth FJ, Cao Y, et al. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes Dev 2009; 23:694-707; PMID:19299559; http://dx.doi.org/10.1101/gad.1765109.
38. Bader D, Masaki T, Fischman DA. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 1982; 95:763-70; PMID:6185504; http://dx.doi.org/10.1083/jcb.95.3.763.
39. Grunau C, Schattevoy R, Mache N, Rosenthal A. MethTools-a toolbox to visualize and analyze DNA methylation data. Nucleic Acids Res 2000; 28:1053-8; PMID:10666443; http://dx.doi.org/10.1093/nar/28.5.1053.